Cargando…

ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis

BACKGROUND: The GALAD and ASAP scores are two well-recognized algorithms to estimate the risk of hepatocellular carcinoma (HCC) based on gender, age, alpha-fetoprotein (AFP), protein induced by vitamin K absence or Antagonist-II (PIVKA-II) and AFP-L3 (included in the GALAD score but not in the ASAP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Si-Yu, Li, Chao, Sun, Li-Yang, Guan, Ming-Cheng, Gu, Li-Hui, Yin, Dong-Xu, Yao, Lan-Qing, Liang, Lei, Wang, Ming-Da, Xing, Hao, Zhu, Hong, Pawlik, Timothy M., Lau, Wan Yee, Shen, Feng, Tong, Xiang-Min, Yang, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576185/ https://www.ncbi.nlm.nih.gov/pubmed/36263214 http://dx.doi.org/10.3389/fonc.2022.1018396

Ejemplares similares

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023)

The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
por: Guan, Ming-Cheng, et al.
Publicado: (2023)

Evaluation of GALAD Score in Diagnosis and Follow-up of Hepatocellular Carcinoma after Local Ablative Therapy
por: Eletreby, Rasha, et al.
Publicado: (2023)

Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2022)

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients
por: Chen, Ping, et al.
Publicado: (2023)

GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients
por: Schotten, Clemens, et al.
Publicado: (2021)

Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2022)

Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma
por: Liu, Yanping, et al.
Publicado: (2022)

Postoperative infectious complications following laparoscopic versus open hepatectomy for hepatocellular carcinoma: a multicenter propensity score analysis of 3876 patients
por: Pu, Jia-Le, et al.
Publicado: (2023)

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients
por: Liu, Miaoxia, et al.
Publicado: (2020)

Surveillance and treatment of primary hepatocellular carcinoma (aka. STOP HCC): protocol for a prospective cohort study of high-risk patients for HCC using GALAD-score
por: Truong, Thai Ngoc, et al.
Publicado: (2023)

Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma—a multicenter propensity score matching analysis
por: Xu, Xin-Fei, et al.
Publicado: (2022)

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study
por: Jia, Hang-Dong, et al.
Publicado: (2021)

Robotic versus laparoscopic right hemicolectomy with complete mesocolic excision: a retrospective multicenter study with propensity score matching
por: Tian, Yue, et al.
Publicado: (2023)

Derivation and Validation of a Prognostic Scoring Model Based on Clinical and Pathological Features for Risk Stratification in Oral Squamous Cell Carcinoma Patients: A Retrospective Multicenter Study
por: Zhou, Jiaying, et al.
Publicado: (2021)

A Pre-Operative Prognostic Score for Patients With Advanced Hepatocellular Carcinoma Who Underwent Resection
por: Xiao, Han, et al.
Publicado: (2021)

Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study
por: Pu, Jia-Le, et al.
Publicado: (2022)

Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis
por: Wang, Kang, et al.
Publicado: (2016)

Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study
por: Wang, Wen-qiang, et al.
Publicado: (2022)

Excitation wavelength optimization improves photostability of ASAP-family GEVIs
por: Xu, Fang, et al.
Publicado: (2018)

eIF5B increases ASAP1 expression to promote HCC proliferation and invasion
por: Wang, Zhen-guang, et al.
Publicado: (2016)

Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study
por: Zhang, Haofeng, et al.
Publicado: (2023)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Perioperative and long-term survival outcomes of laparoscopic versus open hepatectomy for BCLC stage A large hepatocellular carcinoma patients in difficult segments: A two-centre, propensity score matching analysis
por: Ding, Dong-yang, et al.
Publicado: (2023)

Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study
por: Yang, Shi-Ye, et al.
Publicado: (2022)

Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis
por: Liu, Siyu, et al.
Publicado: (2022)

Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Chiang, Chi-Leung, et al.
Publicado: (2021)

Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score?
por: Müller, Lukas, et al.
Publicado: (2021)

Tumor burden score dictates prognosis of patients with combined hepatocellular cholangiocarcinoma undergoing hepatectomy
por: Deng, Gang, et al.
Publicado: (2023)

Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kuo, Yuan-Hung, et al.
Publicado: (2021)

Cumulative Scoring Systems and Nomograms for Predicating Survival in Patients With Glioblastomas: A Study Based on Peripheral Inflammatory Markers
por: Yang, Chao, et al.
Publicado: (2022)

ASAP distributed analysis
por: Munro, Craig, et al.
Publicado: (2007)

Intraoperative low-dose dopamine is associated with worse survival in patients with hepatocellular carcinoma: A propensity score matching analysis
por: Wang, Yan, et al.
Publicado: (2022)

Thermal ablation as an alternative to liver transplantation for hepatocellular carcinoma with clinically significant portal hypertension: propensity score matching study
por: Long, Yinglin, et al.
Publicado: (2023)

Significance of anatomical resection and resection margin status in patients with HBV-related hepatocellular carcinoma and microvascular invasion: a multicenter propensity score-matched study
por: Zhang, Xiu-Ping, et al.
Publicado: (2023)

Identify optimal HAP series scores for unresectable HCC patients undergoing TACE plus sorafenib: A Chinese multicenter observational study
por: Zhu, Yejing, et al.
Publicado: (2023)

Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Kan, Xuefeng, et al.
Publicado: (2020)

Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study
por: Zhu, Di, et al.
Publicado: (2022)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
por: Nie, Guilin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_147psp5ajia27g8g93vpl7thn1